Alliancebernstein L.P. Has $32.18 Million Stake in Agilent Technologies, Inc. (A)

Alliancebernstein L.P. decreased its stake in Agilent Technologies, Inc. (NYSE:A) by 1.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 542,580 shares of the medical research company’s stock after selling 8,715 shares during the period. Alliancebernstein L.P. owned 0.17% of Agilent Technologies worth $32,180,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Bronfman E.L. Rothschild L.P. grew its holdings in shares of Agilent Technologies by 0.8% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 4,658 shares of the medical research company’s stock valued at $276,000 after acquiring an additional 35 shares in the last quarter. Park National Corp OH lifted its stake in Agilent Technologies by 1.1% in the 2nd quarter. Park National Corp OH now owns 4,077 shares of the medical research company’s stock valued at $242,000 after purchasing an additional 43 shares during the last quarter. Trust Co. of Vermont lifted its stake in Agilent Technologies by 1.8% in the 2nd quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock valued at $166,000 after purchasing an additional 50 shares during the last quarter. Neuberger Berman Group LLC lifted its stake in Agilent Technologies by 0.9% in the 1st quarter. Neuberger Berman Group LLC now owns 9,840 shares of the medical research company’s stock valued at $520,000 after purchasing an additional 91 shares during the last quarter. Finally, HL Financial Services LLC lifted its stake in Agilent Technologies by 1.1% in the 2nd quarter. HL Financial Services LLC now owns 8,957 shares of the medical research company’s stock valued at $531,000 after purchasing an additional 94 shares during the last quarter.

TRADEMARK VIOLATION NOTICE: This piece of content was first reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this piece of content on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.chaffeybreeze.com/2017/09/19/alliancebernstein-l-p-has-32-18-million-stake-in-agilent-technologies-inc-a.html.

In related news, CFO Didier Hirsch sold 1,200 shares of the company’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $66.00, for a total transaction of $79,200.00. Following the sale, the chief financial officer now directly owns 164,202 shares in the company, valued at approximately $10,837,332. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Michael R. Mcmullen sold 16,492 shares of the company’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $65.33, for a total transaction of $1,077,422.36. Following the sale, the chief executive officer now owns 211,872 shares in the company, valued at $13,841,597.76. The disclosure for this sale can be found here. Insiders have sold a total of 170,720 shares of company stock valued at $10,795,039 over the last three months.

Shares of Agilent Technologies, Inc. (NYSE A) opened at 66.08 on Tuesday. The firm’s 50-day moving average is $62.57 and its 200 day moving average is $58.21. The firm has a market capitalization of $21.27 billion, a P/E ratio of 34.08 and a beta of 1.30. Agilent Technologies, Inc. has a 12 month low of $42.92 and a 12 month high of $66.42.

Agilent Technologies (NYSE:A) last released its earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same period in the prior year, the firm earned $0.49 EPS. The company’s revenue was up 6.7% compared to the same quarter last year. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post $2.32 EPS for the current year.

Several brokerages recently issued reports on A. Bank of America Corporation raised their target price on shares of Agilent Technologies from $66.00 to $68.00 and gave the company an “equal weight” rating in a research note on Wednesday, August 16th. Morgan Stanley reiterated an “overweight” rating on shares of Agilent Technologies in a research note on Wednesday, August 16th. Deutsche Bank AG set a $68.00 target price on shares of Agilent Technologies and gave the company a “buy” rating in a research note on Wednesday, August 16th. Janney Montgomery Scott raised their target price on shares of Agilent Technologies from $65.00 to $70.00 and gave the company a “buy” rating in a research note on Wednesday, August 16th. Finally, J P Morgan Chase & Co reiterated an “overweight” rating and issued a $70.00 target price on shares of Agilent Technologies in a research note on Wednesday, August 16th. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Agilent Technologies currently has an average rating of “Buy” and an average target price of $63.91.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply